Enolase Inhibitors as Early Lead Therapeutics against Trypanosoma brucei is a research paper published in Pathogens (2023). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Health
Grant: R01AI156382
National Institute of Health
Grant: R21AI171217
National Institute of Health
Grant: R01CA231509
National Institute of Health Center for Biomedical Excellence (COBRE)
Grant: P20GM146584
Call Me Doctor Fellowship
Grant: N/A
National Science Foundation Award for REU Site
Grant: 1757658
REU Site: Nature's machinery through the prism of physics, biology, chemistry and engineering
National Institutes of Health
Grant: 3P20GM146584-02S1
Acquisition of the Agilent Cytation C10 confocal imaging reader for enhancing biomedical research excellence at Clemson University
National Institutes of Health
Grant: 5R01AI156382-03
Development of a multiplexed assay in kinetoplastid parasites to identify probes for glycolysis
National Institutes of Health
Grant: 1R01CA231509-01A1
Pro-Drug Enolase Inhibitors in Precision Oncology
National Institutes of Health
Grant: 1R21AI171217-01A1
Enolase inhibitors as therapeutic leads for Naegleria fowleri infections
Clemson University Creative Inquiry
Call Me Doctor Fellowship (Clemson University)
Fields of Study
Keywords
Sustainable Development Goals